On February 6, 2018 SELLAS Life Sciences Group Inc., (Nasdaq:SLS) (SELLAS), a development-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, reported that Angelos Stergiou, M.D., ScD h.c., President and Chief Executive Officer of SELLAS, will present a corporate overview at the following upcoming conferences (Press release, Sellas Life Sciences, FEB 6, 2018, View Source [SID1234523769]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO CEO & Investor Conference 2018
Date: Tuesday, February 13, 2018
Presentation Time: 2:30 PM ET
Location: New York Marriott Marquis, New York, NY

2018 RBC Capital Markets Healthcare Conference
Date: Wednesday, February 21, 2018
Presentation Time: 2:35 PM ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast of each presentation can be accessed on the investor page of SELLAS’ website at www.sellaslifesciences.com/investors. A replay of each webcast will also be archived for up to 30 days on SELLAS’ website following the conference.